HSBC Holdings
APLT

HSBC Holdings’s Applied Therapeutics APLT Stock Holding History

HSBC Holdings’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,405
Closed -$5.5K – 3020
2025
Q1 		$5.5K Buy
11,405
+133
+1% +$78 ﹤0.01% 2999
2024
Q4 		$9.59K Sell
11,272
-501
-4% -$3.14K ﹤0.01% 3072
2024
Q3 		$98.5K Buy
+11,773
New +$69.4K ﹤0.01% 2805

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

HSBC Holdings's APLT Position: Q2 2025 in Review

HSBC Holdings sold out of Applied Therapeutics (APLT) in Q2 2025, closing a stake of 11,405 shares — an estimated $5.5K sold.

HSBC Holdings first reported a position in APLT in Q3 2024 and held it in 3 quarters. The position peaked at $98.5K in Q3 2024. 75 funds tracked by Wall St. Rank hold APLT as of Q2 2025.

  • HSBC Holdings reported no remaining Applied Therapeutics position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 11,405 Applied Therapeutics shares in Q2 2025, an estimated $5.5K.
  • HSBC Holdings first reported a position in Applied Therapeutics in Q3 2024 and held it in 3 quarters.
  • HSBC Holdings's Applied Therapeutics position peaked at $98.5K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.